Transgene SA (TRGNF)
1.00
0.00 (0.00%)
USD |
OTCM |
Apr 02, 16:00
Transgene Enterprise Value : -47.57M for April 2, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Nicox SA | -- |
| DBV Technologies SA | 984.94M |
| Cellectis SA | 254.25M |
| Adocia SA | -- |
| Innate Pharma SA | -- |
Enterprise Value Related Metrics
| Earnings Yield | -29.24% |